Pieter Reitsma

Chief Scientific officer
VarmX, Leiden, The Netherlands
Leiden, Zuid-Holland, Netherlands

Presentation(s):

• OC 31.3 - Phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of VMX-C001 in healthy subjects

  Monday, June 26, 2023
  11:15 – 11:30 ET

• PB1145 - Coagulation assays for assessing direct Factor Xa inhibitor oral anticoagulant reversal effects

  Tuesday, June 27, 2023
  18:30 – 19:30 ET